Vicente
Soriano Vazquez
Hospital Universitario de Basurto
Bilbao, EspañaPublications in collaboration with researchers from Hospital Universitario de Basurto (16)
2024
-
The incidence of HIV-2 infection in Spain is declining – a registry data analysis
International Journal of Infectious Diseases, Vol. 146
2023
-
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
Journal of Clinical Virology, Vol. 167
-
Susceptibility to hepatitis B virus infection in adults living in Spain
Liver International, Vol. 43, Núm. 5, pp. 1015-1020
-
The slowdown of new infections by human retroviruses has reached a plateau in Spain
Journal of Medical Virology, Vol. 95, Núm. 5
2019
-
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain
Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
-
Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain
AIDS, Vol. 33, Núm. 14, pp. 2167-2172
2017
-
Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
-
Human T-lymphotropic virus type 1 infection and disease in Spain
AIDS, Vol. 31, Núm. 12, pp. 1653-1663
2014
-
HIV-2 and HTLV-1 infections in Spain, a non-endemic region
AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159
-
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194
2009
-
(Enfermedades Infecciosas y Microbiologia Clinica (2009) 27, 4, (222-235))
Enfermedades Infecciosas y Microbiologia Clinica
2008
-
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens
HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313
1997
-
A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients
Journal of Infection, Vol. 35, Núm. 3, pp. 225-230